MedTech Forum 2019: In The Medtech Glasshouse, Industry Need Not Fear Stones
How Fast And How Fully Can Value-Based Health Care Be Integrated Into The Medtech System?
Executive Summary
Medtech’s contribution to health care improvements in Europe over the past 30 years has been a phenomenal journey of success – in patient terms as well as in commercial terms, says MedTech Europe chair Rob ten Hoedt. Local creativity has been able to mine a seam of product innovation that is unmatched anywhere in the world, but the sector is facing massive change and must find ways to cope.
You may also be interested in...
Commission’s D’Acunto Tells EU Industry To Talk Less About Bottlenecks
The medical technology industry has lobbied the European Commission hard because it believes the time it has to comply with the new Medical Device and IVD Regulations is much too short and threatens product availability. But the commission has hit back at these claims.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.